Ranbaxy Laboratories’ arm launches isotretinoin capsules in US

04 Oct 2014 Evaluate

Ranbaxy Laboratories’ wholly owned subsidiary - Ranbaxy Laboratories Inc. (RLI), has launched ABSORICA (isotretinoin) 25mg and 35mg capsules into the US healthcare market. ABSORICA has become the most prescribed branded oral isotretinoin in the US, as per a recent independent survey conducted with dermatologists.

The product is licensed by Ranbaxy from Cipher Pharmaceuticals, Inc. It is indicated for the treatment of severe recalcitrant nodular acne in patients 12 years of age and older.

Ranbaxy Laboratories is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

Peers
Company Name CMP
Sun Pharma Inds. 1746.00
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 910.00
Lupin 2119.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×